Bifogade filer
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Redeye via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
2024-07-15 08:42:00
XVIVO delivered an organic growth surprise at 32% (CER, 32% in Q1) during Q2 a quarter, with a substantial contribution from both the thoracic and abdominal business, whilst the OPEX level is contained. The outlook remains positive, and the critical US Heart study is underway. Our updated Base Case is SEK 575 (460) with a Bull Case of SEK 1,100 (925) and a Bear Case of SEK 165 (115).
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/